基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 5,611.91
成立日期: 26/01/2004
 
分析
市值分佈:
96.94%
大市值
2.46%
中市值
0.58%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 19/09/2026 05:37) 總持有投資項目: 413  
0%
 
100%
     10大 (52.04%)
代號 名稱 佔比% ▼ 持有日期
CBLLCERIBELL INC0.0131/07/2026
STLNStarling Oncology, Inc.0.0131/08/2026
PRTAProthena Corp0.0131/08/2026
VSTMVerastem0.0131/08/2026
NGNENeurogene0.0131/08/2026
PRMEPrime Medicine0.0131/08/2026
ASMBAssembly Biosciences0.0131/08/2026
FLGTFulgent Genetics0.0131/08/2026
SEPNSepterna Inc0.00531/07/2026
RLMDRelmada Therapeutics0.00531/08/2026
PACBPacific Biosciences of California0.00531/07/2026
EYPTEyePoint Inc.0.00531/08/2026
OABIOmniAb0.00531/08/2026
CYHCommunity Health Systems0.00531/08/2026
RCKTRocket Pharmaceuticals0.00431/08/2026
SLPSimulations Plus0.00431/08/2026
CBIOCrescent Biopharma Inc0.00431/07/2026
EBSEmergent BioSolutions Inc.0.00431/08/2026
GDRXGoodRx Holdings0.00431/08/2026
STROSutro Biopharma Inc.0.00431/08/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17   18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.